We looked at clinical estrogen receptor (ER), progesterone receptor (PR), and Her2 status in breast cancer, which are important predictive and prognostic molecular markers currently assessed by molecular immunohistochemistry (IHC) staining14. The gene discussed is PGR; the disease is breast carcinoma.